Menu
Search
|

Menu

Close
X

Hualan Biological Engineering Inc 002007.SZ (Shenzhen Stock Exchange)

32.95 CNY
+0.05 (+0.15%)
As of 3:00 AM EDT
Previous Close 32.90
Open 32.77
Volume 9,280,218
3m Avg Volume 11,171,865
Today’s High 33.27
Today’s Low 32.69
52 Week High 35.60
52 Week Low 19.74
Shares Outstanding (mil) 930.09
Market Capitalization (mil) 25,307.69
Forward P/E 31.59
Dividend (Yield %) 0.40 ( 1.47 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.82 Mean rating from 22 analysts

KEY STATS

Revenue (mm, CNY)
FY19
696
FY18
3,217
FY17
2,368
FY16
1,935
EPS (CNY)
FY19
0.185
FY18
0.817
FY17
0.588
FY16
0.559
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
31.59
32.66
Price to Sales (TTM)
vs sector
12.10
7.91
Price to Book (MRQ)
vs sector
5.92
5.38
Price to Cash Flow (TTM)
vs sector
--
24.36
Total Debt to Equity (MRQ)
vs sector
0.00
14.55
LT Debt to Equity (MRQ)
vs sector
0.00
10.20
Return on Investment (TTM)
vs sector
19.39
14.48
Return on Equity (TTM)
vs sector
19.73
15.78

EXECUTIVE LEADERSHIP

Kang An
Chairman of the Board, General Manager, Since
Salary: --
Bonus: --
Junmin Xie
Chief Financial Officer, Secretary of the Board, Since 2013
Salary: --
Bonus: --
Bei Fan
Executive Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --
Ruowen Pan
Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --
Qiping Wang
Deputy General Manager, Director, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

No.A1, Hualan Avenue
XINXIANG   HEN   453003

Phone: +86373.3559989

HUALAN BIOLOGICAL ENGINEERING, INC. is a China-based company principally engaged in the research, development, production and sales of blood products. It also produces vaccine products and biological engineering products. The Company's main products include human albumins, human immunoglobulin for intravenous injection, human immunoglobulin, human coagulation factors, human rabies immunoglobulin, human tetanus immunoglobulin and influenza vaccines, among others. The Company mainly operates its businesses in domestic markets.

SPONSORED STORIES